Importance Immune checkpoint inhibitors (ICIs) are now a mainstay of cancer treatment.
Although rare, fulminant and fatal toxic effects may complicate these otherwise transformative …

… Although both original and updated studies derived from one trial were included in this
network metaanalysis, we extracted treatment-related adverse events data from the study with the …

… immune checkpoint inhibitors (ICIs) has become standard therapy in many tumor sites. The
aim of this study … to determine whether the incidence of immune-related adverse events (irAEs…

… immune checkpoints is a novel approach in cancer therapy. This strategy may trigger
immune … in patients receiving immune checkpoint inhibitors (ICI) targeting only immune cells …

… Immune checkpoint inhibitor, Cancer, Safety meta-analysis, Randomized clinical trials See
page 4978 for the editorial comment for this article ‘Immune checkpoint inhibitors … the immune …

… In this study, we performed a systematic review and meta-analysis of the reported clinical
trials to evaluate the response and safety of immune checkpoint therapy in patients with …

Immune checkpoint inhibitors (ICIs) can elicit toxicities by inhibiting negative regulators of
adaptive immunity. … We performed a systematic review and meta-analysis of published studies …

… Meta-analysis of within-group change in global quality of life in patients receiving immune
checkpoint inhibitor therapy. Positive values indicate improvement. Random effect models …

Tumor mutational burden (TMB) is a genomic biomarker that predicts favorable responses to
immune checkpoint inhibitors (ICIs). Here, we set out to assess the predictive value of TMB …

… We performed a systematic review and meta-analysis of the published literature to assess …
introduction of immune checkpoint inhibitors (ICIs). The blockage of immunologic checkpoints […